SCYNEXIS to Present Commercial Launch Update for BREXAFEMME® (ibrexafungerp tablets)

BREXAFEMME is a triterpenoid antifungal indicated for the treatment of adult and postmenarchal pediatric females with vulvovaginal candidiasis (VVC), or vaginal yeast infections.